US EditionSpyGlass Pharma Raises $75M Series D Round - Orange County Business Journal
Summary by ocbj.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
SpyGlass Pharma Raises $75M Series D Round - Orange County Business Journal
SpyGlass Pharma Inc. has raised a $75 million Series D round that brings the company closer to commercializing its intraocular lens (IOL). Proceeds from the round, announced at the beginning of June, will help fund two large Phase 3 trials, which are set to begin later this year. “This not only allows us to complete our Phase 3 trials, but extends us from a cash runway well beyond completion of our Phase 3 readout,” Chief Executive Patrick Mo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
